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Abbreviations 
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Abstract  
Galectin-3 has been attributed with a plethora of pro-inflammatory functions due its 
abilities, amongst others, to promote neutrophil activation and the reduction of 
neutrophil recruitment in models of infection in its absence. Conversely, it has also 
been linked to resolution of inflammation through its actions as an opsonin and ability 
to promote efferocytosis of apoptotic neutrophils. Using a self-resolving model of 
peritonitis we have addressed the modulation and role of Gal-3 in acute 
inflammation. We have shown that Gal-3 expression is increased in neutrophils that 
traffic to the inflamed peritoneum and that cellular localisation of this lectin is 
modulated over the course of the inflammatory response. Furthermore, neutrophil 
recruitment to the inflamed peritoneum is increased in Gal-3 null mice over the 
course of the response and this correlates with reduced numbers of 
monocytes/macrophages in the cavities of these mice as well as reduced apoptosis 
and efferocytosis of Gal-3 null neutrophils. These data indicate a role for 
endogenous Gal-3 in neutrophil clearance during acute inflammation.  
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Introduction 
Galectins are a family of beta-galactoside binding proteins that elicit their effects by 
binding to exposed N-acetyllactosamine residues on cells [1]. Several galectins have 
been designated key immunomodulatory roles in a range of pathological settings; of 
these, galectin-3 (Gal-3) is identified as a pro-inflammatory molecule that functions to 
drive the inflammatory response through the activation of innate immune cells and its 
chemoattractant actions [2-5]. During infections with pathogens such as S. 
Pneumoniae, Gal-3 appears to be beneficial for the host with enhanced 
pathogenicity observed in Gal-3 null mice and reduced infection in mice treated with 
recombinant Gal-3 [6, 7]. Such effects are thought to be due to Gal-3 enhancing 
recruitment/activation of neutrophils as well as direct bactericidal actions [6]. 
Administration of recombinant Gal-3 to human neutrophils results in degranulation, 
release of reactive oxygen species and an increase in phagocytic capability [3, 5, 8]. 
With regards to neutrophil trafficking, decreased neutrophil recruitment is seen in the 
lungs of Gal-3 null mice infected with S. Pneumoniae and this can be rescued by 
administration of the recombinant protein [9]; Gal-3 can also act directly as an 
adhesion molecule and promotes adhesion of neutrophils to endothelial cells in vitro 
[7]. The effects of Gal-3 on neutrophil trafficking appear to be specific to particular 
pathogens as no differences were observed in neutrophil trafficking to the lungs in 
Gal-3 null mice infected with E. coli or to air pouches inoculated with the L. Major 
substrain Friedlin when compared to substrain LV39 [10]. Interestingly, both S. 
Pneumoniae and LV39 induced release of Gal-3 into the inflammatory exudate 
whereas E. coli and Friedlin did not, suggesting that it is the presence of Gal-3 in 
inflammatory exudates that functions to drive neutrophil recruitment. This hypothesis 
is supported by the finding that administration of recombinant Gal-3 into the murine 
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air pouch results in neutrophil recruitment [10]. Whether endogenous Gal-3 is 
released and has a role in neutrophil trafficking to other sites of inflammation such as 
the inflamed peritoneal cavity is not clear. Colnot et al. observed reduced recruitment 
of granulocytes in a model of thioglycollate-induced peritonitis in Gal-3 null mice on 
day 4 only, whilst Hsu et al observed reduced numbers of neutrophils on day 1 only 
[11, 12]. Furthermore, it is not clear how Gal-3 promotes neutrophil transmigration 
when it is released into inflammatory exudates or injected into a cavity such as the 
air pouch as it is not chemotactic for neutrophils [9] nor does it appear to modulate 
the levels of major chemokines/cytokines within inflammatory exudates [10]. 
 
As well as the aforementioned studies supporting a role for Gal-3 in driving innate 
immunity, there is evidence to suggest that it may facilitate resolution of inflammation 
through its actions as an opsonin [13]; furthermore, Gal-3 deficient macrophages are 
less efficient at phagocytosing apoptotic neutrophils than wild-type cells [6]. Binding 
of Gal-3 to human neutrophils promotes the exposure of phosphatidylserine without 
inducing apoptosis, a process known to act as an “eat-me” signal for phagocytes; 
suggesting a role for Gal-3 in the clearance of neutrophils [14]. However, evidence 
that treatment of human neutrophils with recombinant Gal-3 delays their 
spontaneous apoptosis and that the rate of apoptosis of neutrophils from Gal-3 null 
mice does not differ from that of wild-type cells is at odds with a pro-resolving 
function [6, 11].  
 
Whilst the studies above have provided evidence that Gal-3 is an important regulator 
of the innate immune system, the modulation of the endogenous protein in innate 
immune cells over the course of an inflammatory response has not been 
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systematically studied. The expression of Gal-3 is reportedly negligible basally in 
both human and murine neutrophils and whether levels are modulated during 
inflammation is not clear, as again contrasting reports exist. Gil et al., demonstrated 
an increase in Gal-3 expression in recruited neutrophils following carrageenan-
induced peritonitis in the rat [15]; while Sato and colleagues showed no increased 
expression of the lectin in murine neutrophils that had been recruited to S. 
Pneumoniae infected alveoli [7]. Human neutrophils express Gal-3 and levels are not 
modulated upon migration through an endothelial monolayer in an in vitro 
transmigration assay in response to interleukin-8 [16].  
 
With this study, we characterised the regulation and function of Gal-3 in neutrophils 
over the course of a self-resolving inflammatory response. Our findings demonstrate 
that Gal-3 expression is increased in neutrophils that have migrated into the inflamed 
peritoneal cavity and that neutrophil numbers are increased in the peritoneal cavities 
of Gal-3 null mice. This is likely due to reduced clearance rather than increased 
trafficking as evidenced by reduced levels of apoptosis of Gal-3 null neutrophils 
coupled with their reduced efferocytosis.  
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Materials and Methods 
Reagents 
All antibodies were purchased from eBioscience, Hatfield, UK. Annexin V-FITC 
apoptosis detection kit was purchased from BD Pharmingen, Oxford, UK. 
CellTrace™ carboxyfluorescein succinimidyl ester was purchased from Invitrogen, 
Paisley, UK. Histopaque 1077 and Zymosan were purchased from Sigma-Aldrich, 
Poole, UK. 
 
Ethics 
All animal studies were conducted with ethical approval from the Queen Mary 
University of London Local Ethical Review Committee and in accordance with the UK 
Home Office regulations (Guidance on the Operation of Animals, Scientific 
Procedures Act, 1986).  
 
Mice 
Male C57BL/6 mice were obtained from Charles River, Margate, UK. Breeding pairs 
of galectin-3 null mice (B6.Cg-Lgals3tm1Po1/J) were provided by the Consortium for 
Functional Glycomics (http://functionalglycomics.org) and a colony was established 
at Charles River, Margate, UK. These mice were on a C57BL/6 background and 
age- and sex-matched controls were used for all experimental work. All animals were 
fed standard laboratory chow and water ad libitum and were maintained on a 12 h 
light-dark cycle under specific pathogen-free conditions. All experiments were 
performed with mice 6-7 weeks old.  
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Peritonitis 
Briefly mice were injected with 1mg zymosan (Sigma) i.p. in 1ml sterile PBS as 
previously described by Ajuebor et al in 1999 [17], 0 h mice received no treatment. 
At 4, 24, 48, 72 and 96 h post injection the mice were anaesthetised, along with 0 h 
controls, with isoflurane and a cardiac puncture was performed to obtain peripheral 
blood. The mice were then sacrificed by cervical dislocation and peritoneal lavages 
were performed with 4ml ice-cold PBS to collect peritoneal exudates. Tibias and 
femurs were collected, cleaned and flushed with sterile PBS using a 25G needle to 
extract bone marrow. Bone marrow cells were then filtered through a 70µm filter and 
washed prior to staining for analysis by flow cytometry.  
 
In some experiments peritonitis was induced using 1mg lyophilised E. coli (strain 
K12; Sigma) i.p. in 1ml sterile PBS. Peritoneal cavities were lavaged as described 
above 4h post-injection.  
 
Flow Cytometry 
Murine cells were incubated with antibodies for Ly6G (eBioscience, clone 1A8) to 
identify neutrophils or a combination of F4/80 and Gr-1 (eBioscience, clone BM8 and 
RB6-8C5 respectively) to identify classical and non-classical 
monocyte/macrophages. Cells were then fixed and permeabilised with BD fixation 
and permeabilisation buffer before addition of anti-Gal-3 antibody (eBioscience, 
clone M3/38) to assess intracellular Gal-3 levels (some cells were incubated with 
Ly6G and Gal-3 without permeabilisation to assess cell surface levels). To determine 
cytosolic expression of Gal-3, MFIs for surface expression were deducted from the 
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MFI values obtained for total expression. In all cases, antibodies or relevant isotype 
controls were incubated at 4°C prior to flow cytometric analysis using FlowJo. 
 
Confocal Microscopy 
Peritoneal lavage cells were seeded onto Ibidi 8 well chamber slides in RPMI and 
allowed to adhere. Following fixation with 1% paraformaldehyde cells were blocked 
with 5% FBS before permeabilisation with 0.05% Triton X-100. Staining for 
intracellular Gal-3 was performed using anti-Gal-3-PE (eBioscience) for 1 h at room 
temperature. Cells were washed three times and then incubated with phalloidin 647 
for 20 mins at room temperature. Finally cells were mounted with ProLong Gold 
Antifade mountant containing DAPI (Thermo Scientific). Immunofluorescence was 
assessed using a Zeiss LSM 710 confocal microscope. Images were processed 
using Zen 2012 (Carl Zeiss Microscopy GmbH) and Adobe Photoshop CS6 (Adobe 
Systems) software. 
 
Adoptive Transfer 
WT mice were euthanised and tibias and femurs were collected, cleaned and flushed 
with RPMI (10% FCS; 2mM EDTA) using a 25G needle as described previously [18]. 
Following centrifugation red blood cells were lysed with 0.2% hypotonic saline for 20 
sec. Bone marrow cells were then washed in RPMI and yield of neutrophils was 
quantified using Turk’s solution. To fluorescently label cells for transfer, neutrophils 
were resuspended in PBS at a concentration of 5 x 106/ml. 5µM CFSE (Thermo 
Scientific) was added and cells were incubated at 37oC for 8 mins. An equal volume 
of FCS was then added to quench excess CFSE and the cells were washed. 
Following two further washes with ice-cold RPMI, the cells were resuspended in ice-
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cold PBS at a density of 25 x 106/ml. 5 x 106 neutrophils were administered to each 
Gal-3 null recipient mouse via the lateral tail vein and 1mg zymosan was injected i.p. 
4 h post-zymosan administration, peritoneal lavages were collected as described 
above and cells were stained with anti-Ly6G to identify neutrophils and Gal-3. Some 
cells were also permeabilised following surface stain with Ly-6G to assess 
intracellular expression of Gal-3.  
 
Gal-3 ELISA 
Gal-3 levels were measured in peritoneal exudates using a commercial ELISA kit 
(R&D systems, Abingdon, UK) according to manufacturer’s instructions.  
 
Apoptosis Assay 
Exudated neutrophils from WT and Gal-3 null mice were collected following 4, 48, 72 
and 96h zymosan-induced peritonitis and labelled with Ly6G. Following this the cells 
were labelled with Annexin V and propidium iodide as per manufacturer’s 
instructions (BD Biosciences) or Zombie NIR™ (viability dye; 1:400 dilution in PBS; 
Biolegend) to assess apoptosis. In some experiments 4h exudated neutrophils were 
cultured overnight in RPMI and assessed the following day at 18h for surface Gal-3 
levels and apoptosis. Gal-3 staining was performed as described above and 
apoptosis was assessed using Annexin V and Zombie NIR™. Viable (Annexin V 
negative, Zombie negative) and late apoptotic (Annexin V, Zombie double positive) 
cells were gated and Gal-3 expression assessed.   
 
Efferocytosis Assay 
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Biogel-elicited macrophages were collected from WT mice as previously described 
[19] and seeded into 24-well plates at 0.5 x 106 cells per well and allowed to adhere. 
Exudated neutrophils from WT and Gal-3 null mice were collected following 4 h 
zymosan-induced peritonitis and labelled with BODIPY®FL for 5 mins at 37oC. 
Following washing, neutrophils were resuspended in RPMI at 2 x 106/ml and 0.5ml 
was added per well of macrophages and incubated for 1h. Following extensive 
washing efferocytosis was quantified using ImageJ software. Images were split into 
their individual red/blue/green channels and the same background threshold was 
applied to all images prior to quantification of fluorescence. 
 
Statistical Analysis 
Statistical significance was assessed using SPSS computer software. Data is 
expressed as mean ± standard error of the mean (SEM) of n experiments. All data 
were tested for normal distribution and power calculations were performed using 
G*Power software [20]. Statistical differences were analysed by one or two-tailed T-
test for 2 groups, one-way analysis of variance (ANOVA) followed by a Bonferroni or 
Dunnetts post hoc test (depending on if comparing all values or each value to a 
control respectively) or two-way ANOVA followed by Bonferroni post hoc test. In all 
cases a P value < 0.05 was considered significant to reject the null hypothesis and 
differences were considered significant.  
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Results 
Modulation of galectin-3 expression in murine neutrophils during inflammation 
To investigate the endogenous levels of Gal-3 over the course of an acute 
inflammatory response, a zymosan-induced peritonitis was performed and monitored 
over 96h, by which time the inflammation had resolved. Due to the discrepancy 
between reports of Gal-3 expression in neutrophils, we fully investigated expression 
levels in three sources of neutrophils, those from the bone marrow, the peripheral 
blood and those that had migrated into the inflamed peritoneal cavity. There was a 
rapid increase in the number of total leukocytes in the peritoneal cavity within 4-24h 
of zymosan administration and this remained elevated over the course of the 
response with increased leukocyte numbers still observed at 96 h compared to basal 
levels (Figure 1A). The neutrophil number in the peritoneal cavity increased sharply 
over 4-24h and then returned back to basal levels within the 96h time course. In 
contrast the monocyte/macrophage numbers declined within the first 4h of zymosan 
treatment and then re-populated the peritoneal cavity over the time course (Figure 
1D). The number of leukocytes within peripheral blood decreased rapidly following 
induction of peritonitis, and then returned to basal levels over the course of the 
response (Figure 1B). Monocytes account for the decrease in total cells seen at 4h, 
which return to basal levels over the time course. Whilst there were no significant 
modulations in the numbers of neutrophils in the peripheral blood, a trend can be 
seen that mirrors the changes in the peritoneal cavity with a decrease as cells 
migrate from the peripheral blood to the peritoneal cavity and then an increase as 
the peripheral blood re-populates (Figure 1E). Although no significant modulation of 
leukocyte number was observed within the bone marrow (Figure 1C), a similar yet 
delayed trend followed the peripheral blood neutrophils with a decrease in cell 
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numbers in the bone marrow approximately 24h later than that seen in the peripheral 
blood. This is likely to account for leukocyte mobilisation to repopulate the peripheral 
circulation (Figure 1F).  
 
Analysis of peritoneal lavage fluid by ELISA revealed baseline levels of 2.155 ± 
0.450 ng/ml Gal-3 within the cavity. These levels increased significantly over the 
peritonitis time course, with peak levels at 72h (7.293 ± 1.239 ng/ml) (Figure 1G). 
Endogenous expression of Gal-3 was minimal in monocyte/macrophages within the 
bone marrow and peripheral blood, yet levels significantly increased in exudate 
peritoneal cells, with peak expression observed at 72h (Figure 1H). As expected, low 
levels of Gal-3 were detected in both peripheral blood [7, 9] and bone marrow-
derived neutrophils, however total levels were significantly increased in 
permeabilised, exudated neutrophils over 72h, with peak expression observed at 24h 
(Figure 1I, J).  
 
Cellular localisation of Gal-3 is modulated in neutrophils during inflammation 
To determine the cellular localisation of Gal-3, flow cytometry was performed on non-
permeabilised versus permeabilised neutrophils (Figure 2A). At 4h post zymosan the 
Gal-3 expressed by murine neutrophils was predominantly intracellular however at 
24h the protein is readily detected on the cell surface, yet by 48h Gal-3 is again 
expressed predominantly in the intracellular compartment of the cell. Confocal 
analysis of peritoneal neutrophils taken at the 4h time-point confirmed the 
intracellular localisation of Gal-3 within migrated neutrophils (Figure 2B).  
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To determine whether the intracellular Gal-3 detected was derived from the 
extracellular environment i.e. being taken up from the inflammatory exudate, or being 
produced by the neutrophils themselves an adoptive transfer experiment was 
performed. CFSE labelled bone marrow neutrophils isolated from WT mice were 
injected i.v. into Gal-3 null mice and a zymosan-induced peritonitis performed. CFSE 
labelled Ly6G positive neutrophils were clearly detectable within peritoneal lavages 
as shown in Figure 3D. Negligible levels of Gal-3 were detectable on the neutrophil 
surface (Figure 3E), whilst Gal-3 was readily detectable in permeabilised cells 
(Figure 3F) indicating the presence of intracellular Gal-3 as shown in Figure 1J.   
 
The role of galectin-3 in neutrophil clearance 
To further investigate the role of neutrophil derived Gal-3, the zymosan-induced 
peritonitis was repeated in Gal-3 null mice, initially at the 4h time-point. This time-
point was chosen as it represents the peak of neutrophil infiltration into the cavity, 
which corresponds with low monocyte/macrophage numbers. Surprisingly, 
significantly higher numbers of leukocytes were observed in the cavities of Gal-3 null 
mice (Figure 4A). Upon further examination, the percentage of neutrophils within the 
cavity was significantly higher in KO mice (Figure 4B), whilst the percentage of 
macrophages was significantly lower (Figure 4C). As was shown in figure 2, surface 
expression of Gal-3 by peritoneal neutrophils was negligible (Figure 4D) whereas it 
was readily detected in permeabilised cells by flow cytometry (Figure 4E).  
 
Neutrophil recruitment in Gal-3 null mice appears to vary in its magnitude depending 
on the inciting stimuli and the site of inflammation. We therefore performed a 
peritonitis experiment were we used E. coli in the place of zymosan. The magnitude 
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of the response was lower overall in terms of neutrophil recruitment and there was 
no difference between the two genotypes of mice in terms of numbers of neutrophils 
recruited to the peritoneal cavity (data not shown).  Again Gal-3 was readily 
detectable within the cytosol of neutrophils that had trafficked to the peritoneum in 
response to both E. coli and zymosan (Supplementary Figure 1) whereas levels 
were low on the surface of zymosan-elicited neutrophils as well as on those elicited 
by E. coli. To investigate whether neutrophils lacking Gal-3 undergo apoptosis at a 
different rate to cells from WT animals, neutrophils collected from the peritoneal 
cavity were cultured overnight and levels of apoptosis were assessed by flow 
cytometry. Upon removal from the cavity the majority of neutrophils were viable in 
both genotypes (Figure 5A). However, following overnight culture, significantly fewer 
neutrophils from the Gal-3 null mice had undergone apoptosis (Figure 5B-E). As Gal-
3 has been implicated in the clearance of neutrophils, experiments were conducted 
to investigate the role of neutrophil-derived Gal-3 on efferocytosis with significantly 
reduced efferocytosis of Gal-3 null neutrophils observed compared to WT neutrophils 
(Figure 5F and G). Interestingly surface expression of Gal-3 was found to be 
increased on apoptotic neutrophils (AnxV/Zombie double positive cells) when 
compared to viable cells (AnxV/Zombie double negative cells) (Figure 5 H and I). 
 
Role of Gal-3 during the resolving phase of the peritonitis model.  
As there is evidence in the literature that Gal-3 may be involved in neutrophil 
clearance, a key facet of the resolution process, leukocyte trafficking was compared 
in Gal-3 null mice and their WT counterparts at 48-96h post-zymosan. At 48h post-
zymosan, total leukocyte counts were comparable for wild type and Gal-3 null mice, 
however at 72h there was a trend towards more leukocytes in the peritoneal cavities 
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of Gal-3 null mice although this did not reach statistical significance and levels had 
declined to those observed in WT mice by 96h (Figure 6A). Interestingly, the 
percentage of exudated neutrophils was significantly higher in Gal-3 null mice at the 
72 and 96h time points (Figure 6B) indicating a potential defect in neutrophil 
clearance in these mice. Assessment of apoptosis by AnnexinV/PI staining revealed 
no differences between the two genotypes of mice with regards to levels of apoptotic 
cells at these later time points (Table 1). As monocytes, particularly non-classical, 
are key players in the resolution of inflammation, the number of both subsets was 
compared between the strains of mice. Approximately 40% of cells recovered were 
non-classical monocytes in both genotypes at 48h and this 40% remained stable in 
galectin-3 null mice up to 96h. This was in contrast to WT mice in which the number 
of non-classical monocytes significantly increased at 96h (Figure 6C). In contrast, 
20% of the cells recovered from the peritoneum were classical monocytes in both 
genotypes and this was not significantly altered at 72h although a trend towards a 
reduced number was seen in the WT mice with approximately 15% of total 
leukocytes being classical monocytes. By 96h the number of classical monocytes 
were negligible in both genotypes of mice (Figure 6D).  
 
Discussion 
The modulation of the inflammatory process, through effects on immune cell biology, 
by members of the galectin family is an ever-growing area of research. The focus 
has however by and large been on T cell driven models of auto-immune disease and 
in the case of Gal-3, cancer. There are several reports describing the effects of Gal-3 
on neutrophil activation and its importance in models of infection where it might 
function as an alarmin by augmenting the inflammatory response [21]. With this 
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study we have expanded the current knowledge of the role of Gal-3 in acute 
inflammation, identifying a role for the endogenous protein in neutrophil apoptosis 
and clearance.  
 
Previous studies have failed to detect expression of Gal-3 intracellularly in murine 
neutrophils, although it is readily detectable on the cell surface [7, 11]. This has led 
to the assumption that effects on neutrophil recruitment in Gal-3 null mice are due to 
a lack of extracellular Gal-3, likely released from cells such as inflammatory 
macrophages. We have confirmed that bone marrow and naïve peripheral blood 
murine neutrophils express low levels of Gal-3. However, in contrast to previous 
findings, we have shown that upon migration to the inflamed peritoneal cavity 
intracellular Gal-3 levels in neutrophils are significantly increased.  
 
Struck by this significant increase in Gal-3 expression upon migration to the 
inflammatory site, we have sought to address the role of neutrophil Gal-3 through 
investigation of the profile of neutrophil recruitment, apoptosis and clearance in the 
zymosan peritonitis model. Increased levels of neutrophil recruitment into the 
peritoneal cavity of Gal-3 null mice were observed at 4, 72 and 96 h. This is in 
contrast to the reported response to thioglycollate in previous studies, as well as in 
models of pneumonia in which neutrophil migration to the peritoneal cavity and lungs 
respectively was reduced in Gal-3 null mice [6, 9, 11, 12]. Such discrepancies may 
be due to the inducing inflammatory stimuli as like zymosan, E. coli infection also 
resulted in a significant enhancement of neutrophil trafficking to the lungs of Gal-3 
null mice [9]. The finding that E. coli increases neutrophil migration to the lungs in 
Gal-3 null mice is in contrast to our findings in the peritoneal cavity. This highlights 
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differences between distinct anatomical sites and might be due to the effects of Gal-
3 on stromal cells at different sites.  Although it should also be noted that a different 
strain of mice was used in this study, which may also account for the observed 
differences. Further similarities exist between these inciting stimuli, which may 
account for the differing responses seen. S. Pneumoniae infection increases Gal-3 
levels in bronchoalveolar lavage fluid as high as 50μg/ml, likewise cutaneous 
infection with L. Major LV39 results in increased levels of extracellular Gal-3 and is 
associated with enhanced neutrophil recruitment. In contrast, infection with E. coli or 
the L. Major substrain Friedlin failed to significantly induce Gal-3 release and a role 
for Gal-3 dependent neutrophil recruitment was not observed. Whilst we observed 
Gal-3 within the peritoneal exudate and levels were significantly raised over the 
course of the response the amount detectable was in the low ng/ml range and as 
was observed following E. coli infection, neutrophil recruitment was increased rather 
than decreased in Gal-3 null mice. Another important factor might be the mechanism 
by which neutrophils traffic to the inflammatory site. Migration in response to 
zymosan and E. coli is known to be dependent on β2 integrins [22], which function to 
allow neutrophils to adhere to and crawl on the endothelium [23]. In contrast, 
neutrophil trafficking to the lungs in response to S. Pneumoniae is independent of β2 
integrins and it is thought that under these circumstances Gal-3 is able to act as an 
adhesion molecule to facilitate neutrophil trafficking, which likely explains the 
requirement for high levels of the protein extracellularly in these models. Our data 
suggests that the observed enhancement of neutrophil numbers within the peritoneal 
cavity of Gal-3 null mice is due to alterations in neutrophil clearance rather than a 
direct role on neutrophil trafficking per se, although this cannot be ruled out.  
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It is important to consider the cellular localisation of galectins when studying their 
actions. Published reports on the effects of Gal-3 have shown cellular localisation 
impacts its function with regards to induction of apoptosis in T cells. Extracellular 
Gal-3 induces T cell apoptosis [24] whereas intracellular Gal-3 inhibits apoptosis 
[25]. With regards to neutrophils, extracellular Gal-3 delays their spontaneous 
apoptosis, whilst no role has been identified for the intracellular protein in murine 
neutrophils with similar rates of apoptosis observed between WT and Gal-3 null cells 
[6]. The present study demonstrated intracellular expression of Gal-3 at 4h post 
zymosan administration, and importantly our data shows an increased surface 
expression of Gal-3 on apoptotic neutrophils. These findings, together with the 
delayed apoptosis observed in Gal-3 null neutrophils recovered from the peritoneal 
cavity, leads us to hypothesise that Gal-3 is externalized by neutrophils and acts as 
an “eat me” signal. As efferocytosis peaks in this model at 6h post-zymosan 
administration [26] it would be expected that more neutrophils would be retained in 
the peritoneal cavity of Gal-3 null mice at the 4h time-point. The role of Gal-3 as an 
“eat-me” signal also explains why there are fewer cells in the peritoneal cavity with 
surface Gal-3 at later time-points (48h onwards) as these cells will have been 
cleared from the peritoneal cavity. Our findings are in contrast to the aforementioned 
study by Farnworth and colleagues [6] and the study of Colnot et al [11] in which no 
defect in apoptosis was observed in neutrophils from Gal-3 null mice. There are 
however differences between the studies; importantly in our study apoptosis was 
assessed following incubation of neutrophils that had emigrated to the inflamed 
peritoneal cavity whilst bone marrow neutrophils were used in the study of Farnworth 
et al. Although Colnot et al assessed levels of apoptosis in neutrophils taken from 
the peritoneal cavity, this was in a model of thioglycollate-induced peritonitis and 
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cells were taken 24h post-administration, whereas we observed reduced levels of 
apoptosis in cells taken at 4h. In-line with the findings of Colnot et al, we did not 
observe differences in the levels of apoptosis of cells collected from the peritoneum 
at later time-points (48-96h). Over the course of the inflammatory response we found 
that the cellular localisation of Gal-3 was altered. As mentioned above, Gal-3 levels 
were increased in the cytosol of neutrophils present within the peritoneal cavity at the 
4h time-point. Our data from the adoptive transfer experiment indicates that the 
neutrophils themselves are a source of Gal-3 although it does not rule out the 
possibility that neutrophils can bind Gal-3 present within the extracellular 
environment. In fact Karlsson et al [13] have shown that apoptotic neutrophils readily 
bind recombinant Gal-3. At 24h Gal-3 was detectable on both the cell surface and 
intracellularly; we hypothesise that satiated neutrophils might translocate Gal-3 to the 
cell surface in order to signal to incoming phagocytes that they need to be cleared. 
This is supported by the observed reduction in efferocytosis of Gal-3 null neutrophils 
by WT biogel-elicited macrophages and the lack of neutrophils with surface Gal-3 
detectable at 48h post-zymosan.  
 
Macrophages are crucial to the resolution process, with essential roles in clearance 
of apoptotic neutrophils [27]. Previous studies have demonstrated defective 
resolution processes in Gal-3 null mice with reduced alternative monocyte activation 
and consequently reduced phagocytic capabilities of these cells [28, 29], this 
correlates with our data showing reduced numbers of non-classical monocytes within 
the peritoneal cavity of Gal-3 null mice during the resolution phase.  
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Together our data highlight a role for endogenous Gal-3 in host phagocyte function, 
enhancing neutrophil apoptosis and clearance. Failure to eliminate dying neutrophils 
leads to tissue damage and dissemination of cellular contents, which can have major 
pathological consequences, particularly with regards to infection.  
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Figure Legends 
Figure 1: Expression of Gal-3 by murine neutrophils during a resolving inflammatory 
response.  Total leukocyte counts in the peritoneal exudate (A), blood (B) and bone 
marrow (C) following zymosan (1mg) challenge in the peritoneal cavity. Differential 
leukocyte counts in the peritoneal exudate (D), blood (E) and bone marrow (F) 
following zymosan (1mg) challenge in the peritoneal cavity. Gal-3 concentration in 
peritoneal exudate fluid following zymosan-induced peritonitis (G). Total Gal-3 
expression in monocyte/macrophages (H) and neutrophils (I) following zymosan 
(1mg) challenge in the peritoneal cavity.  Representative dot plot showing 
neutrophils double-stained for Ly6g and Gal-3 at 4h post zymosan in the bone 
marrow, peripheral blood and peritoneal cavity (J). N = 12 per group for peritoneal 
exudate, 8 per group for peripheral blood and 4 per group for bone marrow. * P < 
0.05, ** P < 0.01 and *** P < 0.001 vs peripheral blood and bone marrow at same 
time point or 0hr control. 
 
Figure 2: Cytosolic and cell surface expression of galectin-3 in murine neutrophils 
taken from the peritoneal exudate at 4, 24 and 48h post zymosan ip. Surface Gal-3 
expression was measured by flow cytometry on Ly6G positive neutrophils and total 
Gal-3 expression was measured following permeabilisation. Cytosolic expression 
was calculated by subtracting the cell surface expression from the total expression 
(A). Gal-3 expression in neutrophils taken from the peritoneal exudate at 4h post 
zymosan as detected by confocal microscopy (B). Scale bar = 5µm. N= 8-12 per 
group. *** P < 0.001 vs cytosol. 
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Figure 3: WT neutrophils exhibit increased Gal-3 expression upon transmigration to 
the peritoneal cavities of Gal-3 null mice. Bone marrow neutrophils were isolated 
from WT mice, labelled with CFSE and administered i.v. to Gal-3 null mice, which 
subsequently underwent a zymosan (1mg) induced peritonitis. Peritoneal cavities 
were lavaged at 4 h and analysed by flow cytometry. Neutrophils were identifiable by 
their characteristic FSC/SSC profile (A). Following doublet exclusion (B), Ly6G 
positive neutrophils were identified (C). WT Ly6G positive neutrophils were identified 
by their positive CFSE staining (D). Surface (E) and total (F) Gal-3 expression was 
measured on CFSE negative (neutrophils from Gal-3 null mice) and CFSE positive 
cells (neutrophils from WT mice) by flow cytometry and representative histograms 
are shown.   
 
Figure 4: Gal-3 null mice demonstrate altered leukocyte trafficking. Total leukocyte 
counts (A), % neutrophils (B) and % macrophages (C) in the peritoneal exudate at 
4h post zymosan (1mg) challenge. Surface (D) and total (E) Gal-3 expression was 
measured on Ly6G positive neutrophils by flow cytometry and representative 
histograms are shown.  N= 4-7 per group, * = P < 0.05;*** P< 0.0001.  
 
Figure 5: Gal-3 null mice demonstrate reduced levels of apoptosis. % viable (A), 
early apoptotic (B) and late apoptotic (C) cells following overnight culture of 
peritoneal exudate cells. Representative dot-plots, following overnight culture of 
peritoneal exudate cells (taken 4h post-zymosan), showing cell viability (zombie NIR) 
and phosphatidylserine exposure (AnxV) in KO (D) and WT (E) of exudated 
leukocytes. WT biogel-elicited macrophages were incubated with BODIPY®FL -
labelled peritoneal exudate cells following overnight culture. Efferocytosis was 
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quantified using ImageJ software (F). Representative images used for the data 
analysis are shown (G). Gal-3 levels were assessed on the surface of viable (AnxV-
/zombie-) and late apoptotic (AnxV+/zombie+) cells by flow cytometry (H and I). N= 4-
7 per group, * = P < 0.05;*** P< 0.0001.  
 
Figure 6: Gal-3 null mice demonstrate dysregulated resolution of inflammation 
compared to wild type controls. Gal-3 null mice and age- and sex-matched wild type 
controls were injected with 1mg zymosan ip and peritoneal exudates were collected 
during the resolution period (48-96 h). Total leukocyte counts (A), % neutrophils (B), 
% non-classical monocytes (C) and % classical monocytes (D) in peritoneal 
exudates following zymosan (1mg) administration. N= 5 per group, * = P < 0.05.  
 
 
 






